Follow
Isabelle Ray-Coquard
Isabelle Ray-Coquard
Centre Leon Berard & Universite Claude Bernard Lyon I
Verified email at lyon.unicancer.fr
Title
Cited by
Cited by
Year
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials …
A Du Bois, A Reuss, E Pujade‐Lauraine, P Harter, I Ray‐Coquard, ...
Cancer 115 (6), 1234-1244, 2009
17722009
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial
E Pujade-Lauraine, F Hilpert, B Weber, A Reuss, A Poveda, G Kristensen, ...
Obstetrical & Gynecological Survey 69 (7), 402-404, 2014
16642014
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised …
E Pujade-Lauraine, JA Ledermann, F Selle, V Gebski, RT Penson, ...
The lancet oncology 18 (9), 1274-1284, 2017
16382017
Olaparib plus bevacizumab as first-line maintenance in ovarian cancer
I Ray-Coquard, P Pautier, S Pignata, D Pérol, A González-Martín, ...
New England Journal of Medicine 381 (25), 2416-2428, 2019
14882019
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, ...
The lancet oncology 18 (1), 75-87, 2017
11452017
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ...
Annals of Oncology 30 (5), 672-705, 2019
10272019
Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO
JY Blay, S Bonvalot, P Casali, H Choi, M Debiec-Richter, AP Dei Tos, ...
Annals of Oncology 16 (4), 566-578, 2005
10162005
Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor–positive, human epidermal growth factor receptor 2–negative metastatic …
T Bachelot, C Bourgier, C Cropet, I Ray-Coquard, JM Ferrero, G Freyer, ...
Journal of Clinical Oncology 30 (22), 2718-2724, 2012
8722012
Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome
M Gobert, I Treilleux, N Bendriss-Vermare, T Bachelot, S Goddard-Leon, ...
Cancer research 69 (5), 2000-2009, 2009
8562009
Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European Organisation for …
S Sleijfer, I Ray-Coquard, Z Papai, A Le Cesne, M Scurr, P Schöffski, ...
Journal of clinical oncology 27 (19), 3126-3132, 2009
7672009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
I Ray-Coquard, C Cropet, M Van Glabbeke, C Sebban, A Le Cesne, ...
Cancer research 69 (13), 5383-5391, 2009
7662009
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
J Bohlius, K Schmidlin, C Brillant, G Schwarzer, S Trelle, J Seidenfeld, ...
The Lancet 373 (9674), 1532-1542, 2009
7192009
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study
N Penel, BN Bui, JO Bay, D Cupissol, I Ray-Coquard, ...
J Clin Oncol 26 (32), 5269-74, 2008
6962008
Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing
F Ducimetière, A Lurkin, D Ranchère-Vince, AV Decouvelaere, M Péoc'h, ...
PloS one 6 (8), e20294, 2011
6052011
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism …
I Ray-Coquard, JY Blay, A Italiano, A Le Cesne, N Penel, J Zhi, F Heil, ...
The lancet oncology 13 (11), 1133-1140, 2012
5912012
Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
ESMO/European Sarcoma Network Working Group
Annals of oncology: official journal of the European Society for Medical …, 2014
5262014
Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial
A Le Cesne, JY Blay, I Judson, A Van Oosterom, J Verweij, J Radford, ...
Journal of Clinical Oncology 23 (3), 576-584, 2005
5192005
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux, JY Blay, N Bendriss-Vermare, I Ray-Coquard, T Bachelot, ...
Clinical Cancer Research 10 (22), 7466-7474, 2004
5142004
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of …
JY Blay, A Le Cesne, I Ray-Coquard, B Bui, F Duffaud, C Delbaldo, ...
Journal of clinical oncology 25 (9), 1107-1113, 2007
5002007
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure
S George, JY Blay, PG Casali, A Le Cesne, P Stephenson, SE Deprimo, ...
European journal of cancer 45 (11), 1959-1968, 2009
4432009
The system can't perform the operation now. Try again later.
Articles 1–20